Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine CR vs IR in Major Depression
NCT00368303Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in major depressive disorder (MDD), sponsored by GSK. Started Dec 2006; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00368303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368303.